US Oncology Network is a leading provider of comprehensive cancer care across the United States, connecting patients with specialized physicians and advanced treatment options. The network emphasizes coordinated care, streamlined referral pathways, and data-informed decision making to improve patient outcomes.
Through a national infrastructure, US Oncology Network supports community practices and academic centers in delivering guideline-based oncology services. This structure enables faster access to diagnostics, personalized therapies, and supportive care resources for individuals facing cancer.
| Network Attribute | Description | Impact on Patients | Key Metric |
|---|---|---|---|
| Geographic Reach | Multi-state presence with clinic sites in urban and suburban areas | Reduced travel burden for initial consultation and follow-up | Coverage in over 30 states |
| Specialty Access | Medical oncology, hematology, surgical oncology, and supportive services | One-stop coordination of complex care needs | 100+ specialty clinicians |
| Technology Platform | Integrated electronic health records and telehealth tools | Enhanced communication and remote monitoring | 95% chart completion rate |
| Clinical Trials | Access to phase II and III trials through cooperative groups | Opportunity for cutting-edge therapies close to home | 200+ active trials |
Patient Referral and Navigation
US Oncology Network offers structured referral pathways that streamline the movement from primary care or preliminary diagnostics to specialized oncology evaluation. Navigation teams help coordinate appointments, clarify treatment plans, and address barriers that might delay care.
For physicians, the network provides clear criteria for referral, reducing administrative friction and enabling timely specialty input. Patients benefit from a guided journey where each handoff is documented and tracked for continuity and quality.
Treatment Options and Clinical Trials
Within the network, patients have access to a broad range of treatment modalities, including chemotherapy, immunotherapy, targeted therapy, and supportive symptom management. Each care plan is reviewed by multidisciplinary teams to align with the latest evidence.
Clinical trials embedded in the network give eligible individuals early access to investigational agents and novel combinations. This integration of research and care accelerates the adoption of innovative therapies into routine practice.
Quality Outcomes and Safety
US Oncology Network prioritizes measurable quality outcomes, tracking response rates, survival metrics, and patient-reported experiences. Standardized protocols and performance dashboards support consistent delivery of high-reliability care.
Safety processes include real-time adverse event monitoring and rapid intervention pathways. Regular audits and feedback loops ensure that deviations from best practice are identified and corrected quickly across the network.
Key Takeaways for Patients and Providers
- Nationwide infrastructure supports faster access to specialized oncology care
- Integrated technology improves communication and care coordination
- Robust clinical trial portfolio provides access to innovative therapies
- Quality and safety metrics guide continuous improvement
- Streamlined referral pathways reduce delays and enhance patient experience
FAQ
Reader questions
How do I get referred to US Oncology Network as a patient?
Referrals are initiated by your primary care physician or specialist, who completes a standardized referral form and shares relevant records. A care coordinator then contacts you to schedule an appointment at the most convenient network location.
What types of cancer are treated within the network?
The network manages a broad spectrum of malignancies, including breast, lung, colorectal, prostate, hematologic, and rare cancers. Specialized tumor boards review complex cases to tailor multidisciplinary treatment strategies.
Are clinical trials available through US Oncology Network?
Yes, numerous phase II and III trials are offered across major treatment centers. Eligibility screening is conducted by study coordinators, and informed consent is reviewed in detail before participation.
How does US Oncology Network handle follow-up and survivorship care?
After active treatment, patients are enrolled in structured survivorship programs that include scheduled surveillance, wellness planning, and early intervention for late effects. Remote monitoring tools and nurse-led calls help maintain continuity beyond the clinic.